These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9424749)

  • 1. [System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
    de las Nieves M; Poveda F; Queipo de Llano MP; González-Hermoso C
    Sangre (Barc); 1997 Oct; 42(5):430-1. PubMed ID: 9424749
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of systemic mast cell disorders.
    Worobec AS
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):659-87, vii. PubMed ID: 10909045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of malignant and benign systemic mastocytosis].
    Mezei P; Bencsik Z; Vicze B; Simon K; István L; Pajor L
    Orv Hetil; 1999 Oct; 140(41):2297-300. PubMed ID: 10603744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphocytic ascites revealing systemic mastocytosis].
    Essner C; Thiefin G; Diebold MD; Pignon B; Caulet T; Zeitoun P
    Gastroenterol Clin Biol; 1995 Nov; 19(11):948-51. PubMed ID: 8746056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to interferon alfa-2b in a patient with systemic mastocytosis.
    Kluin-Nelemans HC; Jansen JH; Breukelman H; Wolthers BG; Kluin PM; Kroon HM; Willemze R
    N Engl J Med; 1992 Feb; 326(9):619-23. PubMed ID: 1370856
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical stable systemic mastocytosis with interferon alpha-2b therapy.
    Hübner C; Wedding U; Sträter J; Limberg B; Stremmel W
    J Intern Med; 1997 Jun; 241(6):529-33. PubMed ID: 10497631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis with malabsorption, myelofibrosis, and massive ascites.
    Reisberg IR; Oyakawa S
    Am J Gastroenterol; 1987 Jan; 82(1):54-60. PubMed ID: 3799581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of three patients with systemic mastocytosis with interferon alpha-2b.
    Worobec AS; Kirshenbaum AS; Schwartz LB; Metcalfe DD
    Leuk Lymphoma; 1996 Aug; 22(5-6):501-8. PubMed ID: 8882964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha-2b in the treatment of myelofibrosis.
    Furesi L; Laghi Pasini F; Forconi S
    Haematologica; 1990; 75(6):587-9. PubMed ID: 2098307
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.
    Hebballi S; Akiki S; Bareford D
    J Clin Pathol; 2012 Aug; 65(8):762-3. PubMed ID: 22412053
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy.
    Petit A; Pulik M; Gaulier A; Lionnet F; Mahe A; Sigal M
    J Am Acad Dermatol; 1995 May; 32(5 Pt 2):850-3. PubMed ID: 7722042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis--a case treated with interferon alpha and radiotherapy.
    Harrison BD; Ashford RA; Hatton CS
    Clin Lab Haematol; 1994 Sep; 16(3):291-4. PubMed ID: 7828417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign systemic mastocytosis: report of 2 cases].
    Velloso ED; Beitler B; Chamone DA
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):94-8. PubMed ID: 1843375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic congenital mastocytosis with universal skin involvement].
    Krahl J; Baldauf P; Stoermer D
    Hautarzt; 1999 Dec; 50(12):893-6. PubMed ID: 10663026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beneficial effect of interferon alfa-2a in a case of splenic lymphoma with circulating villous cells].
    Ferrer Marco R; Ruiz Guinaldo MA; Martínez Martínez J; Navarro Gonzalo I
    Sangre (Barc); 1993 Dec; 38(6):503-4. PubMed ID: 8171390
    [No Abstract]   [Full Text] [Related]  

  • 17. alpha-Interferon in myelofibrosis: a case report.
    Dalla KP; Zeigler ZR; Shadduck RK
    Br J Haematol; 1994 Mar; 86(3):654-6. PubMed ID: 8043450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic mastocytosis as a rare cause of diffuse gastrointestinal hemorrhage.
    Black JS; Feldmann M; Leon S
    Am Surg; 2009 May; 75(5):429-30. PubMed ID: 19445297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systemic mastocytosis as a cause of osteoporosis].
    Kluin-Nelemans JC
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1924-5. PubMed ID: 8927174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneosystemic congenital mastocytosis].
    Labeille B; Kremp O; Lok C; Teillac D; Risbourg B; Denoeux JP; de Prost Y
    Ann Dermatol Venereol; 1990; 117(11):805-6. PubMed ID: 2099685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.